GGrantIndex
Sort

21,281 grants matching influenza

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities

$2,241,256
S. Mark Tompkins · University Of Georgia · N01 · FY2025 · AI

Medicinal Chemistry and Lead Development Core - SR

$2,240,361
Ashish Kumar Pathak · University Of Alabama At Birmingham · U19 · FY2020 · AI

Medicinal Chemistry and Lead Development Core - SR

$2,240,360
Ashish Kumar Pathak · University Of Alabama At Birmingham · U19 · FY2021 · AI

Multi Union National Worker and Worker-Trainer Health and Safety Training program

$2,240,344
Shari Lynn Glines-Allen · International Chemical Workers Union · U45 · FY2022 · ES

Oklahoma Center for Respiratory and Infectious Diseases

$2,236,246
Lin Liu · Oklahoma State University Stillwater · P20 · FY2022 · GM

Center for Lung Biology and Disease

$2,235,991
Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2023 · GM

T cell Development and Regeneration

$2,234,461
Avinash Bhandoola · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Oklahoma Center for Respiratory and Infectious Diseases

$2,233,766
Lin Liu · Oklahoma State University Stillwater · P20 · FY2021 · GM

Oklahoma Center for Respiratory and Infectious Diseases

$2,233,269
Lin Liu · Oklahoma State University Stillwater · P20 · FY2020 · GM

Development/production of seasonal and pandemic influenza DNA vaccines

$2,233,172
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2009 · AI

COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,

$2,229,415
Ted Ross · University Of Georgia · N01 · FY2022 · AI

The Genome Analysis Core

$2,224,710
Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI

Discovery of novel synthetic IL-1 adjuvants

$2,223,085
Jay Evans · University Of Montana · N01 · FY2023 · AI

RESPIRATORY PATHOGENS RESEARCH CENTERS (RPRC)

$2,222,145
David Topham · University Of Rochester · N01 · FY2017 · AI

Development/production of H5 influenza DNA plasmid vaccine

$2,219,937
Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)

$2,214,805
Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr · UM1 · FY2021 · AI

Laboratory And Pre-clinical Studies Of Parainfluenza Viruses

$2,214,754
Brian Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

PANDEMIC INFLUENZA PROJECT 2 ELECTRONIC LABORATORY DATA EXCHANGE TO SUPPORT PANDE

$2,214,108
Ruth Lynfield · Minnesota State Dept Of Health · U90 · FY2008 · TP

Systems Approach to Immunity and Inflammation

$2,213,320
Richard J Ulevitch · Scripps Research Institute, The · U19 · FY2019 · AI

Oklahoma Center for Respiratory and Infectious Diseases

$2,209,879
Lin Liu · Oklahoma State University Stillwater · P20 · FY2019 · GM

Clinical Trials of Parainfluenza and Respiratory Syncytial Virus Vaccines

$2,209,409
Brian Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Systems Approach to Immunity and Inflammation

$2,207,462
Richard J Ulevitch · Scripps Research Institute, The · U19 · FY2020 · AI

CEIRS Influenza Data Processing and Coordinating Center (DPCC)

$2,207,451
Gillian Air · Digital Infuzion, Inc. · N01 · FY2016 · AI

Influenza responses and repertoire in vaccination, infection and tonsil organoids.

$2,207,151
Mark M Davis · Stanford University · U19 · FY2023 · AI

Oklahoma Center for Respiratory and Infectious Diseases

$2,205,488
Lin Liu · Oklahoma State University Stillwater · P20 · FY2018 · GM